Every year, more than 600,000 people worldwide are seriously injured or killed by snakebites.

We save limbs and lives of snakebite victims from this Category A neglected tropical disease.

Asclepius Snakebite Foundation (ASF) is an international non-profit organization dedicated to helping victims of snakebite around the world by:

A snakebite victim receives antivenom administered through an IV in their right forearm. The left hand has swelling and bruising from a snakebite.

Our Organization

The Asclepius Snakebite Foundation (ASF) was established at Venom Week 2018, where a diverse group of herpetologists, healthcare professionals, and altruistic volunteers united to confront the issue of snakebites globally. We have adopted an integrated approach that combines bench research, field conservation, medical treatments, and public health initiatives.

Dr. Cellou Balde holding a venomous snake in front of the ASF Guinea Snakebite Clinic

Our Story

ASF was established because we saw a need to empower and give a voice to colleagues in other countries who were doing amazing work but lacked the resources and support to effect major change. We work on the ground with local partners to gain an understanding of an area's needs and to implement solutions that bring healing to communities.

Why Snakebites?

The World Health Organization (WHO) declared snakebite a Neglected Tropical Disease. Each year, 2.7 million people are bitten by venomous snakes. 500,000 are disabled as a result of these bites, and up to 138,000 die. 20-40% of victims are children. We support the WHO goal to cut the number of global deaths from snakebites in half by the year 2030. Contact us to find out ways you can help.

Snakebite Education

Educational conferences play a crucial role in fostering collaboration and innovation in the field of snakebite management. Join the ASF team this September at the Columbus Venom Conference, where an exceptional lineup of speakers will share their expertise to improve snakebite outcomes for victims worldwide! Continuing education will be available for healthcare professionals in human or veterinary medicine.